-
1دورية أكاديمية
المؤلفون: Eichstadt S, Tang JY, Solis DC, Siprashvili Z, Marinkovich MP, Whitehead N, Schu M, Fang F, Erickson SW, Ritchey ME, Colao M, Spratt K, Shaygan A, Ahn MJ, Sarin KY
المصدر: Clinical, Cosmetic and Investigational Dermatology, Vol Volume 12, Pp 933-942 (2019)
مصطلحات موضوعية: dystrophic epidermolysis bullosa, genotype, phenotype, incidence, prevalence, Dermatology, RL1-803
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Eichstadt S, Tang JY, Solis DC, Siprashvili Z, Marinkovich MP, Whitehead N, Schu M, Fang F, Erickson SW, Ritchey ME, Colao M, Spratt K, Shaygan A, Ahn MJ, Sarin KY
المصدر: Clinical, Cosmetic and Investigational Dermatology, Vol Volume 14, Pp 679-680 (2021)
مصطلحات موضوعية: dystrophic epidermolysis bullosa, genotype, phenotype, incidence, prevalence, Dermatology, RL1-803
وصف الملف: electronic resource
-
3دورية أكاديمية
-
4
المؤلفون: Whitson, RJ, Lee, A, Urman, NM, Mirza, A, Yao, CY, Brown, AS, Li, JR, Shankar, G, Fry, MA, Atwood, SX, Lee, EY, Hollmig, ST, Aasi, SZ, Sarin, KY, Scott, MP, Epstein, EH, Tang, JY, Oro, AE
المصدر: Whitson, RJ; Lee, A; Urman, NM; Mirza, A; Yao, CY; Brown, AS; et al.(2018). Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nature Medicine, 24(3), 271-281. doi: 10.1038/nm.4476. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/8hs9c3sv
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______325::93553ba47d1b5fc46da3b0f02f345fa5
http://www.escholarship.org/uc/item/8hs9c3sv -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
المؤلفون: Novelli F; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Yoshikawa Y; Department of Genetics, School of Medicine, Hyogo Medical University, Hyogo 663-8501, Japan., Vitto VAM; Department of Medical Sciences, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara 44121, Italy., Modesti L; Department of Medical Sciences, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara 44121, Italy., Minaai M; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Pastorino S; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Emi M; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Kim JH; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Kricek F; NBS-C Bioscience & Consulting GmbH, Vienna 1230, Austria., Bai F; Shanghai Institute for Advanced Immunochemical Studies, Shanghai Tech University, Shanghai 201210, China., Onuchic JN; Center for Theoretical Biological Physics, Rice University, Houston, TX 77005., Bononi A; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Suarez JS; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Tanji M; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Favaron C; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Zolondick AA; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816.; Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI 96822., Xu R; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Takanishi Y; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Wang Z; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Sakamoto G; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Gaudino G; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Grzymski J; Desert Research Institute, Reno, NV 89512., Grosso F; Mesothelioma Unit, Azienda Ospedaliera Santo Antonio and Santo Biagio (SS) Antonio e Biagio e Cesare Arrigo, Alessandria 15121, Italy., Schrump DS; Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-1201., Pass HI; Department of Cardiothoracic Surgery, New York University, New York, NY 10016., Atanesyan L; Department of Oncogenetics, MRC Holland, Amsterdam 1057, the Netherlands., Smout J; Department of Oncogenetics, MRC Holland, Amsterdam 1057, the Netherlands., Savola S; Department of Oncogenetics, MRC Holland, Amsterdam 1057, the Netherlands., Sarin KY; Department of Dermatology, Stanford University Medical Center, Stanford, CA 94305., Abolhassani H; Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17165, Sweden., Hammarström L; Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17165, Sweden., Pan-Hammarström Q; Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17165, Sweden., Giorgi C; Department of Medical Sciences, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara 44121, Italy., Pinton P; Department of Medical Sciences, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara 44121, Italy., Yang H; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816., Carbone M; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI 96816.
المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Jul 16; Vol. 121 (29), pp. e2405231121. Date of Electronic Publication: 2024 Jul 11.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
مواضيع طبية MeSH: DNA Repair*/genetics , Tumor Suppressor Proteins*/genetics , Tumor Suppressor Proteins*/metabolism , Germ-Line Mutation* , Ubiquitin-Protein Ligases*/genetics , Ubiquitin-Protein Ligases*/metabolism , Mesothelioma*/genetics , Genetic Predisposition to Disease* , Calcium Signaling*/genetics, Humans ; Female ; Male ; Middle Aged ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Apoptosis/genetics ; Fibroblasts/metabolism ; Asbestos/toxicity ; Genomic Instability
-
8دورية أكاديمية
المؤلفون: Chen ML; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.; Center for Digital Health, Stanford University, Stanford, CA, USA., Kim J; Center for Digital Health, Stanford University, Stanford, CA, USA., Naik HB; Department of Dermatology, University of California, San Francisco, CA, USA., Aleshin MA; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA., Sarin KY; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA., Barnes LA; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA., Linos E; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.; Center for Digital Health, Stanford University, Stanford, CA, USA.
المصدر: The British journal of dermatology [Br J Dermatol] 2024 Jul 08. Date of Electronic Publication: 2024 Jul 08.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
-
9دورية أكاديمية
المؤلفون: Youn GM; Department of Dermatology, Stanford University School of Medicine, Stanford, California., Sarin KY; Department of Dermatology, Stanford University School of Medicine, Stanford, California., Chiou AS; Department of Dermatology, Stanford University School of Medicine, Stanford, California., Chen JK; Department of Dermatology, Stanford University School of Medicine, Stanford, California., Honari G; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
المصدر: JAMA dermatology [JAMA Dermatol] 2024 Jul 01; Vol. 160 (7), pp. 780-782.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
مواضيع طبية MeSH: Dermatitis, Atopic* , Parents*/psychology , Electronic Nicotine Delivery Systems*/statistics & numerical data, Humans ; Child ; Female ; Male ; Child, Preschool ; Vaping/adverse effects ; Adolescent ; Adult
-
10دورية أكاديميةEffect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.
المؤلفون: Sarin KY; Department of Dermatology, Stanford University Medical Center, Stanford, CA, USA., Bradshaw M; NFlection Therapeutics, Boston, MA, USA., O'Mara C; NFlection Therapeutics, Boston, MA, USA., Shahryari J; NFlection Therapeutics, Boston, MA, USA., Kincaid J; NFlection Therapeutics, Boston, MA, USA., Kempers S; Minnesota Clinical Study Center, New Brighton, MN, USA., Tu JH; Skin Search of Rochester, Inc., Rochester, NY, USA., Dhawan S; Center for Dermatology Clinical Research Inc., Fremont, CA, USA., DuBois J; DermResearch Inc., Austin, TX, USA., Wilson D; The Education and Research Foundation Inc., Lynchburg, VA, USA., Horwath P; NFlection Therapeutics, Boston, MA, USA., de Souza MP; NFlection Therapeutics, Boston, MA, USA., Powala C; NFlection Therapeutics, Boston, MA, USA., Kochendoerfer GG; NFlection Therapeutics, Boston, MA, USA., Plotkin SR; NFlection Therapeutics, Boston, MA, USA., Webster GF; NFlection Therapeutics, Boston, MA, USA., Le LQ; Department of Dermatology, UT Southwestern Medical Center, Dallas, TX, USA.; Department of Dermatology, University of Virginia School of Medicine, Charlottesville, VA, USA.
المصدر: Science advances [Sci Adv] 2024 May 03; Vol. 10 (18), pp. eadk4946. Date of Electronic Publication: 2024 May 01.
نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
مواضيع طبية MeSH: Neurofibromatosis 1*/drug therapy , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/pharmacology , Protein Kinase Inhibitors*/adverse effects , Skin Neoplasms*/drug therapy , Skin Neoplasms*/pathology, Humans ; Female ; Male ; Adult ; Middle Aged ; Neurofibroma/drug therapy ; Neurofibroma/pathology ; Neurofibroma/metabolism ; Young Adult ; Adolescent ; Treatment Outcome ; Administration, Topical ; Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors ; Mitogen-Activated Protein Kinase Kinases/metabolism